Search hospitals > Louisiana > Baton Rouge
Our Lady of the Lake Physicians Group - Medical Oncology
Claim this profileBaton Rouge, Louisiana 70809
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
81 reported clinical trials
2 medical researchers
Summary
Our Lady of the Lake Physicians Group - Medical Oncology is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. Our Lady of the Lake Physicians Group - Medical Oncology is involved with conducting 81 clinical trials across 133 conditions. There are 2 research doctors associated with this hospital, such as Marshall P. Stagg and David S. Hanson.Area of expertise
1Lung Cancer
Global LeaderStage II
Stage I
Stage IV
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Marshall P. StaggLSU Health Baton Rouge-North Clinic2 years of reported clinical research
Studies Lung Cancer
Studies Cancer
41 reported clinical trials
85 drugs studied
David S. HansonMary Bird Perkins Cancer Center6 years of reported clinical research
Expert in Lung Cancer
Studies Breast Cancer
38 reported clinical trials
82 drugs studied
Clinical Trials running at Our Lady of the Lake Physicians Group - Medical Oncology
Lung Cancer
Ovarian Cancer
Cancer
Breast Cancer
Uterine Cancer
Breast cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Bladder Cancer
Melanoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Biobank Collection
for Cancer
This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.
Recruiting1 award N/A10 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Our Lady of the Lake Physicians Group - Medical Oncology?
Our Lady of the Lake Physicians Group - Medical Oncology is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. Our Lady of the Lake Physicians Group - Medical Oncology is involved with conducting 81 clinical trials across 133 conditions. There are 2 research doctors associated with this hospital, such as Marshall P. Stagg and David S. Hanson.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.